» Articles » PMID: 17895380

Exhaled Methyl Nitrate As a Noninvasive Marker of Hyperglycemia in Type 1 Diabetes

Overview
Specialty Science
Date 2007 Sep 27
PMID 17895380
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Recent technical advances allow detection of several hundred volatile organic compounds (VOCs) in human exhaled air, many of which reflect unidentified endogenous pathways. Our group has previously estimated plasma glucose levels in healthy adults during a standard oral glucose tolerance test via exhaled VOC analysis. As a result of the metabolic characteristics of hyperglycemia in the diabetic (low insulin and increased free fatty acids and ketones), we hypothesized that different exhaled VOC profiles may be present in children with type 1 diabetes mellitus (T1DM) during spontaneous hyperglycemia. Exhaled methyl nitrate strongly correlated specifically with the acute, spontaneous hyperglycemia of T1DM children. Eighteen experiments were conducted among 10 T1DM children. Plasma glucose and exhaled gases were monitored during either constant euglycemia (n = 5) or initial hyperglycemia with gradual correction (n = 13); all subjects received i.v. insulin and glucose as needed. Gas analysis was performed on 1.9-liter breath samples via gas chromatography using electron capture, flame ionization, and mass selective detection. Among the approximately 100 measured exhaled gases, the kinetic profile of exhaled methyl nitrate, commonly present in room air in the range of 5-10 parts per trillion, was most strongly statistically correlated with that of plasma glucose (P = 0.003-0.001). Indeed, the kinetic profiles of the two variables paralleled each other in 16 of 18 experiments, including repeat subjects who at different times displayed either euglycemia or hyperglycemia.

Citing Articles

Artificial Neural Processing-Driven Bioelectronic Nose for the Diagnosis of Diabetes and Its Complications.

Jang W, Yi D, Nguyen T, Lee Y, Lee E, Choi J Adv Healthc Mater. 2023; 12(26):e2300845.

PMID: 37449876 PMC: 11469111. DOI: 10.1002/adhm.202300845.


Assessment of an exhaled breath test using ultraviolet photoionization time-of-flight mass spectrometry for the monitoring of kidney transplant recipients.

Feng S, Xiang C, He Y, Li Z, Zhao Z, Liu B Mol Biomed. 2023; 4(1):19.

PMID: 37353649 PMC: 10289997. DOI: 10.1186/s43556-023-00130-6.


Smelling the Disease: Diagnostic Potential of Breath Analysis.

Sharma A, Kumar R, Varadwaj P Mol Diagn Ther. 2023; 27(3):321-347.

PMID: 36729362 PMC: 9893210. DOI: 10.1007/s40291-023-00640-7.


A preliminary screening system for diabetes based on in-car electronic nose.

Weng X, Li G, Liu Z, Liu R, Liu Z, Wang S Endocr Connect. 2023; 12(3).

PMID: 36662684 PMC: 9986382. DOI: 10.1530/EC-22-0437.


Metabolites From Trypanosome-Infected Cattle as Sensitive Biomarkers for Animal Trypanosomosis.

Getahun M, Ngiela J, Makwatta J, Ahuya P, Simon T, Kamau S Front Microbiol. 2022; 13:922760.

PMID: 35910617 PMC: 9329068. DOI: 10.3389/fmicb.2022.922760.


References
1.
Lopes H, Morrow J, Stojiljkovic M, Goodfriend T, Egan B, Stoijiljkovic M . Acute hyperlipidemia increases oxidative stress more in African Americans than in white Americans. Am J Hypertens. 2003; 16(5 Pt 1):331-6. DOI: 10.1016/s0895-7061(03)00041-4. View

2.
Moser B, Bodrogi F, Eibl G, Lechner M, Rieder J, Lirk P . Mass spectrometric profile of exhaled breath--field study by PTR-MS. Respir Physiol Neurobiol. 2005; 145(2-3):295-300. DOI: 10.1016/j.resp.2004.02.002. View

3.
Rieder J, Lirk P, Ebenbichler C, Gruber G, Prazeller P, Lindinger W . Analysis of volatile organic compounds: possible applications in metabolic disorders and cancer screening. Wien Klin Wochenschr. 2001; 113(5-6):181-5. View

4.
Phillips M, Herrera J, Krishnan S, Zain M, Greenberg J, Cataneo R . Variation in volatile organic compounds in the breath of normal humans. J Chromatogr B Biomed Sci Appl. 1999; 729(1-2):75-88. DOI: 10.1016/s0378-4347(99)00127-9. View

5.
Kamboures M, Blake D, Cooper D, Newcomb R, Barker M, Larson J . Breath sulfides and pulmonary function in cystic fibrosis. Proc Natl Acad Sci U S A. 2005; 102(44):15762-7. PMC: 1276081. DOI: 10.1073/pnas.0507263102. View